World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 29 July 2022
Main ID:  NCT02425891
Date of registration: 21/04/2015
Prospective Registration: Yes
Primary sponsor: Hoffmann-La Roche
Public title: A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
Scientific title: A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer
Date of first enrolment: June 23, 2015
Target sample size: 902
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02425891
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  Phase 3
Countries of recruitment
Argentina Australia Austria Belgium Bosnia and Herzegovina Brazil Canada Chile
Colombia Costa Rica Czech Republic Czechia Denmark Estonia Finland France
Germany Greece Guatemala Hong Kong Hungary Italy Japan Korea, Republic of
Latvia Mexico Norway Panama Poland Portugal Romania Russian Federation
Serbia Singapore Slovenia Spain Sweden Switzerland Taiwan Thailand
Turkey Ukraine United Kingdom United States
Contacts
Name:     Clinical Trials
Address: 
Telephone:
Email:
Affiliation:  Hoffmann-La Roche
Key inclusion & exclusion criteria
Health Condition(s) or Problem(s) studied
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 17/05/2021
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02425891
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history